APLS vs AVB · rev $781.4M vs P/E 23, rev $2.91B
Apellis Pharmaceuticals Inc (APLS) versus AvalonBay Communities Inc (AVB) — a side-by-side from cached financials, not a winner call.
Apellis Pharmaceuticals Inc (APLS) is a biotechnology company listed on US.
AvalonBay Communities Inc (AVB) is a reit - residential company listed on US.
Latest reported APLS revenue for 2024-12-31 was $781.4M. Net income was -$197.9M. Revenue was up 97.0% from 2023-12-31 to 2024-12-31. APLS currently screens at market cap $2.29B.
Latest reported AVB revenue for 2024-12-31 was $2.91B. Net income was $1.08B. Revenue was up 5.3% from 2023-12-31 to 2024-12-31. AVB currently screens at market cap $26.84B and trailing P/E 23.4.
APLS currently screens at market cap $2.29B. AVB currently screens at market cap $26.84B and trailing P/E 23.4.
Not investment advice. Open the APLS and AVB stock pages for the full models.
Not investment advice.